Press Release

Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Stratosvir secures support from Cell and Gene Therapy Catapult to advance innovative anticancer therapeuticsStratosvir secures support from Cell and Gene Therapy Catapult to advance innovative anticancer therapeuticsCGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovationsCGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovationsNew data shows continued growth in advanced therapy clinical trials in the UK for 2025, with the number of early-stage trials remaining highNew data shows continued growth in advanced therapy clinical trials in the UK for 2025, with the number of early-stage trials remaining highMinaris and Cell and Gene Therapy Catapult announce collaboration to advance delivery methods for cell and gene therapiesMinaris and Cell and Gene Therapy Catapult announce collaboration to advance delivery methods for cell and gene therapiesCGT Catapult leads industry consortium developing universal test to increase the safety and efficiency of stem cell therapiesCGT Catapult leads industry consortium developing universal test to increase the safety and efficiency of stem cell therapiesCGT Catapult to take part in consortium aiming to improve the sustainability of CAR-T manufacturingCGT Catapult to take part in consortium aiming to improve the sustainability of CAR-T manufacturingCGT Catapult annual review highlights the role of advanced therapies in supporting Government ambitions for public health and economic growthCGT Catapult annual review highlights the role of advanced therapies in supporting Government ambitions for public health and economic growthNew evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economyNew evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economyUnderstanding life with Beta ThalassemiaUnderstanding life with Beta ThalassemiaCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsMHRA introduces regulations that allow decentralised manufacturing of therapiesMHRA introduces regulations that allow decentralised manufacturing of therapiesCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new ChairCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new Chair